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Acquisition of blaNDM-1 in bacterial species, such as Proteus mirabilis that is intrinsically resistant to
tetracycline, tigecycline and colistin, will make clinical treatment extremely difficult. Here, we characterized an
NDM-1-producing clinical isolate of P. mirabilis (PM58) that displayed an extensively drug-resistant (XDR)
phenotype, susceptible only to aztreonam. Molecular analysis revealed that PM58 harbored both a
conjugative NDM-1 plasmid and a novel Salmonella genomic island 1 variant on chromosome.
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Acquisition of blaNDM-1 in bacterial species, such as Proteus mirabilis that is intrinsically resistant to tetracycline, tigecycline and
colistin, will make clinical treatment extremely difficult. Here, we characterized an NDM-1-producing clinical isolate of P. mira-
bilis (PM58) that displayed an extensively drug-resistant (XDR) phenotype, susceptible only to aztreonam. Molecular analysis
revealed that PM58 harbored both a conjugative NDM-1 plasmid and a novel Salmonella genomic island 1 variant on
chromosome.
Global dissemination of New Delhi metallo--lactamase 1(NDM-1), an Ambler class B metallo--lactamase (MBL)
able to hydrolyze all -lactams except monobactams, in Gram-
negative bacteria represents a great threat for public health (1).
Transmission of blaNDM-1 is of especial concernwith bacterial spe-
cies of intrinsic antibiotic resistance, such as Proteus mirabilis that
is intrinsically resistant to tetracycline, tigecycline and colistin,
which will make clinical treatment extremely difficult.
Salmonella genomic island 1 (SGI1), consisting of a conserved
backbone structure and a multidrug resistance (MDR) region, is
integrated into the chromosome specifically at the last 18 bp of the
3=-end of the thdF gene and was initially reported in Salmonella
enterica serovar TyphimuriumDT104 (2). To date, multiple vari-
ants of SGI1 have been discovered, and they are classified from
SGI1-A to SGI1-Y, corresponding to various structures of the
MDR region. Since several novel variants of SGI1, such as SGI1-L
and SGI1-U to SGI1-Y, have been identified in P. mirabilis, this
species is considered an acceptor of SGI independent of Salmo-
nella spp. (3–5). Recently, the blaNDM-1 gene was reportedly inte-
grated into a novel SGI1 variant, named PGI1 (Proteus genomic
island 1), in a P. mirabilis clinical isolate (6). However, the
blaNDM-1 carrying PGI1 was nontransferable in the presence of
helper plasmid pR55, and this PGI1-harboring isolate remained
susceptible to multiple antibiotics, including meropenem, ertap-
enem, gentamicin, and fosfomycin (6).Here, we describe a clinical
extensively drug resistant (XDR) P. mirabilis isolate that harbors
both a conjugative NDM-1 plasmid and a novel SGI1 variant on
chromosome.
A 3-year-old girl was admitted to the emergency department of
The First Affiliated Hospital of Zhengzhou University on August
10, 2013, with a diagnosis of spinal cord injury (SCI) caused by a
knife injury. After the surgery operation on August 11, intrave-
nous cefathiamidine was given empirically (1 g administered 2
times/day) for 1 week to prevent bacterial infections. After receiv-
ing treatment, the patient was in a stable condition and was trans-
ferred to the rehabilitation department for restorative treatment.
Unfortunately, the patient developed symptoms of frequent and
urgent micturition and urodynia on December 10, 2013, and was
treated with gentamicin bladder irrigations via catheter (20 mg
administered 2 times/day). On December 15, an XDR P. mirabilis
isolate named PM58 in this study was obtained from the urine
culture. According to the drug resistance pattern of PM58, antibi-
otic treatmentwas switched to aztreonam (30mg/kg administered
as an intravenous drip 2 times/day). After 1 week of treatment, the
girl recovered, and the urine was negative for P. mirabilis.
Antimicrobial susceptibilities were tested by themicrodilution
method and the agar dilution method (for fosfomycin) following
the CLSI guidelines, and theMIC results were interpreted accord-
ing to the CLSI breakpoints (7). PM58 was resistant to all the
tested antibiotics used for treatment of infections caused by En-
terobacteriaceae, with the exception of aztreonam. (Table 1). The
positive result for the imipenem-ethylenediaminetetraacetic acid
(EDTA) double-disk synergy test indicated that PM58 produced
metallo--lactamase (MBL). PCR and sequencing analysis iden-
tified the MBL and -lactamase genes blaNDM-1 and blaTEM-1, as
well as other genes conferring resistance to aminoglycoside
(rmtB), quinolones (qnrA1), tetracyclines (tet[C], tet[J]), chlor-
amphenicol (floR), and fosfomycin (fosA3). Primers used for de-
tecting these resistance genes were described in previous studies
(8–11). S1-pulsed field gel electrophoresis and Southern blotting
demonstrated that the blaNDM-1 gene, together with rmtB and
fosA3 genes, was located on an85-kb plasmid (see Fig. S1 in the
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supplemental material), designated pNDM-PM58. Conjugative
assay was performed using an established method to evaluate the
transferability of pNDM-PM58 (8). The result showed that this
plasmid was successfully transferred to Escherichia coli J53 at a
frequency of 9.4  107 per donor cell. In addition, all of the
resistance determinants detected in PM58 except blaTEM-1 were
cotransferred with the blaNDM-1 gene to E. coli J53 by the mating
experiment. This was confirmed by using PCR and sequencing.
The surrounding genetic environment of the blaNDM-1 gene on
pNDM-PM58was sequenced by amodified randomprimer walk-
ing strategy (12), yielding a 12,146-bp fragment (GenBank acces-
sion number KP662515; Fig. 1). The blaNDM-1 genewas embedded
TABLE 1 Antibiotic susceptibilities of P. mirabilis PM58, its transconjugant PM58-J53, and recipient strain E. coli J53
Antimicrobial category Antimicrobial agent
MIC (g/ml)
PM58 PM58-J53 E. coli J53
Penicillins Ampicillin 256 256 8
Penicillins -lactamase inhibitors Ampicillin-sulbactam 256 256 8
Antipseudomonal penicillins -lactamase inhibitors Piperacillin-tazobactam 256 256 2
Non-extended-spectrum cephalosporins Cefazolin 256 256 2
Extended-spectrum cephalosporins Ceftazidime 256 256 0.5
Cefepime 256 256 0.25
Cephamycins Cefotetan 256 256 1
Carbapenems Imipenem 64 64 	0.125
Meropenem 8 8 	0.125
Monobactams Aztreonam 1 1 	0.125
Fluoroquinolones Levofloxacin 32 8 	0.125
Aminoglycosides Gentamicin 64 64 1
Amikacin 64 64 1
Folate pathway inhibitors Trimethoprim-sulfamethoxazole 32 32 1
Phenicols Chloroamphenicol 64 64 4
Phosphonic acids Fosfomycin 1,024 1,024 2
Tetracyclines Doxycycline 128 64 2
Tetracycline NDa 64 2
Glycylcyclines Tigecycline NDa 0.5 0.25
Polymyxins Colistin NDa 1 0.5
a ND, not determined: P. mirabilis is intrinsically resistant to tetracycline, tigecycline and colistin.
FIG 1 Genetic environment of the blaNDM-1 gene in the pNDM-PM58 of P. mirabilis 58 and structural comparison with Klebsiella pneumoniae plasmid pLK78
(Genbank accession number KJ440075), E. coli plasmid pEcNDM1-4 (Genbank accession number JX469383), pRpNDM1-1 (Genbank accession number
JX515588) from Raoultella planticola, and theMDR region of SGI1-O from P. mirabilis. The boxed arrows indicate the positions and directions of transcription
of the genes. The gray-shaded areas represent regions sharing99% DNA identity.
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in a complex class 1 integron, flanked by two copies of ISCR1
elements (ISCR1-1 and ISCR1-2) located in the same orientation.
Similar structures were reported in E. coli andRaoultella planticola
isolates from China in a very recent study (13). However, the
resistance gene cassettes and genetic arrangement within the com-
plex class 1 integron in PM58 were different from those of
pEcNDM1-4, a 58-kb plasmid carrying blaNDM-1 in E. coli, and
pRpNDM1-1, a 280-kb plasmid carrying blaNDM-1 in R. planticola
(13) (Fig. 1). In PM58, a classical class 1 integron carrying a dfrA1-
orfC cassette array was located upstream of the ISCR1-1 (imme-
diately downstream of the trpF gene) and exhibited 99.74% (3,519
of 3,528 bp) nucleotide sequence identity to a corresponding seg-
ment of InSGI1-O, an In4 type integron that has been previously
identified in P. mirabilis in China (14). Notably, the qacE
1/sul1-
ISCR1-1-trpF-bleMBL-blaNDM-1-
ISAba125 cassette array is quite
similar to that of plasmid pLK78 (Genbank accession number
KJ440075) (15), which differs by the deletion of a 597-bp seg-
ment-contained oriIS site immediately downstream of the
ISCR1-1 element (Fig. 1). It has been documented that the ISCR1-
like elements might be responsible for the mobilization of
blaNDM-1 inEnterobacteriaceae and non-Enterobacteriaceae species
via the rolling circle replication process (13, 15, 16). The acquisi-
tion of the blaNDM-1-carrying segment in the complex class 1 in-
tegron in PM58may be related to ISCR1-2, since the oriIS site was
identified downstream of this element.
The presence of an InSGI1-O-like segment on pNDM-PM58
prompted us to investigate the possible presence of an SGI1-like
element in PM58. A 35-kb chromosomal DNA fragment of PM58
was obtained by using PCR mapping and DNA sequencing, as
described previously (5). It contained a novel SGI1 variant of 34.1
kb, named SGI1-Z in this study. The complete structure of SGI1-Z
(backbone andMDR region) is shown in Fig. 2. Sequence analysis
revealed that SGI1-Z was integrated between the chromosomal
genes thdF and hipB, and the 18-bp sequences of the chromosomal
attB site (direct repeat right [DR-R]) and the SGI1 attP site (direct
repeat left [DR-L]) were confirmed. In addition, theDR-R located
109 bp downstream of open reading frame (ORF) S044 diverged
in 1 bp from the DR-L (Fig. 2). Compared with SGI1 backbone of
S. TyphimuriumDT104, only seven single-base changes were ob-
served. The MDR region of SGI1-Z belonging to the In4-type
integron was integrated between the SGI1 backbone genes res
(S027) and S044. The structure of the MDR region was further
confirmed by long-range PCR (LR-PCR) and DNA sequencing
using forward primer LR-F and reverse primer LR-R (located in
the conserved regions of the S026 and hipB genes, respectively),
which yielded an 8,645-bp amplicon that contained the MDR re-
gion of SGI1-Z. InSGI1-Z (6,755 bp) contained a dfrA12-orfF-
aadA2 cassette array conferring resistance to trimethoprim, spec-
tinomycin, and streptomycin. Comparative analysis of DNA
sequence revealed InSGI1-Z was nearly identical to an In4-like
backbone structure located on plasmid pBDE0502 from a clinical
isolate of E. coli (GenBank accession number EU056266) (17).
Given that the SGI1 is considered a hot spot for acquiring complex
In4-type integrons (18), we speculate that InSGI1-Z might be de-
rived from pBDE0502-like plasmids. The observations of an
InSGI1-O-like structure on pNDM-PM58 and InSGI1-Z corre-
sponding to an In4-type integron on pBDE0502 suggest the ex-
change of gene cassettes between plasmid and chromosome via
integron-mediated recombination.
In conclusion, our study represents the first report of coexis-
tence of a self-transferable NDM-1 plasmid and a novel chromo-
somal SGI1 variant in an XDR P. mirabilis isolate that is suscepti-
ble only to aztreonam. It is unclear how this XDR isolate
originated in the patient. It could have originated from the treat-
ment process due to overuse or inappropriate use of antibiotic
therapy. In this case, the patient received intravenous cefathia-
midine for aweek to prevent bacterial infection, but this strategy is
non-evidence based and not plausible, whichmight have served as
a selection pressure for the emergence of the XDR isolate. Alter-
natively, the patient could have been infected by the XDR P. mi-
rabilis isolate from other sources. Regardless, rational and evi-
dence-based use of antibiotics should be emphasized in clinical
therapy. A recent review recommended a combination of two or
even three antibiotics among aminoglycoside, fosfomycin, high-
dose tigecycline, and colistin for the treatment of infections
caused by carbapenem-resistant EnterobacteriaceaewithMICs for
carbapenems higher than 8g/ml (19). Since P.mirabilis is intrin-
sically resistant to tigecycline and colistin, the emergence and
spread of XDR P. mirabilis carrying plasmid-mediated resistance
to carbapenems (blaNDM-1), fosfomycin (fosA3), and aminoglyco-
sides (rmtB) will severely compromise the utility of combination
regimens in treating infections attributed to P. mirabilis. Thus,
FIG 2 Schematic view of SGI1-Z integrated into the chromosome of P. mirabilis 58, and comparison of the MDR region of SGI1-Z (InPm58) with an In4-like
backbone structure on E. coli plasmid pBDE0502 (EU056266). The boxed arrows indicate the positions and directions of transcription of the genes. The
gray-shaded areas represent regions sharing99%DNA identity. DR-L andDR-R represent the 18-bp direct repeats at the ends of SGI1. CS, conserved segment;
IR, inverted repeat.
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detection and surveillance of XDR P. mirabilis and its resistance
elements are urgently warranted to control their further spread.
Nucleotide sequence accession number. The sequence of the
novel complex class 1 integron carrying blaNDM-1 and the com-
plete SGI1-Z sequence were submitted to GenBank under acces-
sion numbers KP662515 and KP662516, respectively.
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